Figure 1

Incidence of Gastrointestinal side effects before and after switchover to extended release metformin XR in patients completing the 6 month study. * vs metformin p = 0.013.
Incidence of Gastrointestinal side effects before and after switchover to extended release metformin XR in patients completing the 6 month study. * vs metformin p = 0.013.